Updated: February 23, 2021 12:11 PM
Created: February 23, 2021 12:05 PM
The leaders of the drug companies making the coronavirus vaccines are testifying before Congress. The Energy and Commerce Committee is asking drugmakers to explain delays in vaccine production and distribution.
Rep. Paul Tonko is a member of the committee.
John Young, Pfizer’s chief business officer, testified that they’ve shipped 40 million doses of its vaccine to the United States as of last week.
Pfizer says improvements to several of their U.S. factories have increased vaccine production.
“We are on track to make 120 million doses avail for shipment by the end of March and an additional 80 million doses by the end of May,” he said. “We anticipate all 300 million contracted doses made available for shipment to the point of use as directed by the U.S. government by the end of July.”
Young also testified that trials of the Pfizer vaccine in pregnant women started last week and trials on children ages 11 to 15 will begin soon.
The Centers for Disease Control will be reviewing the Johnson & Johnson vaccine results on Friday to decide if it will get authorization.
Copyright 2021 - WNYT-TV, LLC A Hubbard Broadcasting Company